Clinical Trial Details
EORTC-20981
Back to Clinical Trials Database
Intergroup Collaborative Study (EORTC 20981) "Rituximab (Mabthera*) in remission induction and maintenance treatment of relapsed / resistant follicular non-Hodgkin's lymphoma : a phase III randomized clinical trial" lymphoma : a phase III randomised clinical trial - Intergroup Collaborative Study (EORTC 20981) Including Amenmdment 4 (28.6.2000)
| Trial Status | All trial activities ended |
|---|---|
| Dates |
Date of activation: 21-May-1999 Date Step1 close: 26-Apr-2004 Date Step2 close: 09-Dec-2005 |
| Data management at EORTC | Yes |
| Design |
Phase 3 Randomized open label |
| Targeted Sample size | EORTC Groups: 752 |
| Treatment | |
| Study Staff | |
| Type of cancer | |
| Participating groups | |
| Protocol summary | http://clinicaltrials.gov/study/NCT00004179 |
| NCT number | NCT00004179 |
